1) The study aimed to determine if a one-page memory and organizational aid could improve the capacity of Alzheimer's patients to provide informed consent for clinical trials. 2) Alzheimer's patients were randomly assigned to either receive the standard consent process or the standard process plus the one-page memory aid. 3) Experts independently judged those who received the memory aid to be more capable of providing informed consent, with a higher percentage deemed competent compared to the control group.